In addition, silencing the LAG3–FGL1 interaction by either genetic knockout or antibody blockade promoted anti-tumor immunity, as manifested by reduced growth of MC38 colon carcinoma cells in inoculated mice. Here, FGL1 is linked to neoplasm.